Drugs / NNC 0070-0002-0182
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00665665 | Nov 2007 → Oct 2008 | metabolic disease, obesity disorder | Novo Nordisk A/S | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC 0070-0002-0182 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00665665 ↗ |
| Route | Subcutaneous | “for s.c. injection” NCT00665665 ↗ |